DXCM — DEXCOM INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1093557 ·
Last close
$82.04
Market Cap
$30.60B
52W High
$92.59
52W Low
$56.72
ADV30
4,579,417
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,344,500,000 | 864,400,000 | 327,200,000 | 275,100,000 | 6,238,800,000 | 961,400,000 | 3,703,400,000 |
| Jun 2026 | 1,308,400,000 | 830,000,000 | 318,300,000 | 249,100,000 | 6,455,300,000 | 1,105,000,000 | 3,833,900,000 |
| Mar 2026 | 1,191,900,000 | 750,300,000 | 255,300,000 | 199,500,000 | 6,633,300,000 | 1,118,200,000 | 3,676,400,000 |
| Dec 2025 | 1,259,600,000 | 792,700,000 | 323,000,000 | 267,300,000 | 6,339,900,000 | 917,700,000 | 3,593,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,209,200,000
Investing CF
$292,500,000
Financing CF
$-3,178,300,000
CapEx
$-477,400,000
Dividends Paid
—
Buybacks
$-1,503,600,000
EPS Diluted TTM
$2.55
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$3,157,600,000
Inventory
$770,700,000
Receivables
$1,205,200,000
ST Investments
$856,500,000
EBIT TTM
$1,275,800,000
Pretax Income TTM
$1,262,400,000
Interest Exp TTM
$13,400,000
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,104,399,872
EBITDA
$1,490,800,000
Free Cash Flow
$1,021,162,496
Enterprise Value
$30,218,170,368
Total Cash
$1,817,900,032
Total Debt
$1,341,900,032
Shares Out
372,950,922
Trailing EPS
$2.54
Book Value
$6.80
ROE
37.7%
ROA
11.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,662,000,000 | 911,800,000 | 836,300,000 | 6,339,900,000 | 3,593,900,000 | 2,746,000,000 | 1,440,700,000 |
| Dec 2024 | 4,033,000,000 | 600,000,000 | 576,200,000 | 6,484,500,000 | 4,381,900,000 | 2,102,600,000 | 989,500,000 |
| Dec 2023 | 3,622,300,000 | 597,700,000 | 541,500,000 | 6,264,500,000 | 4,195,900,000 | 2,068,600,000 | 748,500,000 |
| Dec 2022 | 2,909,800,000 | 391,200,000 | 341,200,000 | 5,391,700,000 | 3,259,900,000 | 2,131,800,000 | 669,500,000 |
TTM Snapshot
Revenues TTM
$4,969,200,000
NetIncome TTM
$999,700,000
OpCashFlow TTM
—
Assets (Latest)
$6,455,300,000
Forward EPS
$3.13
Max Pain — expiry 2026-12-18
max pain strike: $75.00 · spot: $82.52 · call oi: 11,840 · put oi: 7,208
Expected Move to 2026-12-18:
±$8.32
(10.09%) —
implied range
$74.19 –
$90.84
· ATM straddle on $85.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PHG | KONINKLIJKE PHILIPS NV | $29.22B | $29.89 | — |
| WST | WEST PHARMACEUTICAL SERVICES INC | $28.85B | $414.12 | — |
| MDLN | Medline Inc. | $33.11B | $37.68 | — |
| FSNUY | Fresenius SE & Co. KGaA | $33.30B | $14.78 | — |
| RMD | RESMED INC | $33.46B | $237.85 | — |
News headlines (Yahoo Finance, 1h cache)
DexCom Sees Record New Patients in 2026 as Medicare Coverage Decision Looms
2026-11-18 07:12 · Yahoo
Are Wall Street Analysts Predicting DexCom’s Stock Will Climb or Sink?
2026-11-17 18:13 · Yahoo
Is A Medicare Delay The Biggest Risk For DexCom Stock?
2026-11-16 15:47 · Yahoo
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
2026-11-13 11:22 · Yahoo
DexCom (DXCM) Could Be 32% Undervalued Following Health Canada G7 Pregnancy Clearance
2026-11-12 08:15 · Yahoo
How Pregnancy Device Approval At DexCom (DXCM) Has Changed Its Investment Story
2026-11-12 07:11 · Yahoo
Is DexCom Stock Cheaper Now That Its Multiple Has Fallen?
2026-11-11 21:17 · Yahoo
Dexcom Announces Upcoming Conference Presentation
2026-11-10 14:00 · Yahoo
Advancing type 1 diabetes care during pregnancy: a Canadian first
2026-11-09 14:00 · Yahoo
What Is Behind The Move In DexCom Stock?
2026-11-07 12:49 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.